A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 22; no. 14_suppl; p. 4515
Main Authors Stadler, W. M., Halabi, S., Ernstoff, M. S., Barrier, R., Davila, E., Picus, J., Small, E. J.
Format Journal Article
LanguageEnglish
Published 15.07.2004
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2004.22.14_suppl.4515